Molecular and Cellular Biology, December 1999, p. 8314-8325, Vol. 19, No. 12
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Department of Biological
Sciences,1 Integrated Program in
Cellular,
Received 25 May 1999/Returned for modification 30 June
1999/Accepted 7 September 1999
A novel member of the p62dok family of
proteins, termed DOKL, is described. DOKL contains features of
intracellular signaling molecules, including an N-terminal PH
(pleckstrin homology) domain, a central PTB (phosphotyrosine binding)
domain, and a C-terminal domain with multiple potential tyrosine
phosphorylation sites and proline-rich regions, which might serve as
docking sites for SH2- and SH3-containing proteins. The DOKL gene is
predominantly expressed in bone marrow, spleen, and lung, although
low-level expression of the RNA can also be detected in other tissues.
DOKL and p62dok bind through their PTB domains
to the Abelson tyrosine kinase in a kinase-dependent manner in both
yeast and mammalian cells. DOKL is phosphorylated by the Abl tyrosine
kinase in vivo. In contrast to p62dok, DOKL
lacks YxxP motifs in the C terminus and does not bind to Ras
GTPase-activating protein (RasGAP) upon phosphorylation. Overexpression of DOKL, but not p62dok, suppresses
v-Abl-induced mitogen-activated protein (MAP) kinase activation but has
no effect on constitutively activated Ras- and epidermal growth
factor-induced MAP kinase activation. The inhibitory effect requires
the PTB domain of DOKL. Finally, overexpression of DOKL in NIH 3T3
cells inhibits the transforming activity of v-Abl. These results
suggest that DOKL may modulate Abl function.
*
Corresponding author. Mailing address: Room 1127 HHSC,
Columbia University College of Physicians and Surgeons, 701 West 168 St., New York, NY 10032. Phone: (212) 305-3794. Fax: (212) 305-8692. E-mail: goff{at}cuccfa.columbia.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|